Canada markets closed

Cytokinetics, Incorporated (CYTK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
65.27+0.93 (+1.45%)
At close: 04:00PM EDT
66.38 +1.11 (+1.70%)
After hours: 04:31PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.83B
Enterprise Value 6.97B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)836.67
Price/Book (mrq)N/A
Enterprise Value/Revenue 925.18
Enterprise Value/EBITDA -15.25

Trading Information

Stock Price History

Beta (5Y Monthly) 0.68
52-Week Change 367.51%
S&P500 52-Week Change 322.38%
52 Week High 3110.25
52 Week Low 325.98
50-Day Moving Average 368.93
200-Day Moving Average 351.82

Share Statistics

Avg Vol (3 month) 31.95M
Avg Vol (10 day) 31.23M
Shares Outstanding 5104.58M
Implied Shares Outstanding 6104.58M
Float 8102.32M
% Held by Insiders 10.56%
% Held by Institutions 1112.71%
Shares Short (Apr 15, 2024) 414.04M
Short Ratio (Apr 15, 2024) 45.79
Short % of Float (Apr 15, 2024) 421.97%
Short % of Shares Outstanding (Apr 15, 2024) 413.43%
Shares Short (prior month Mar 15, 2024) 414.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jun 25, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-7,620.69%

Management Effectiveness

Return on Assets (ttm)-33.73%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)7.53M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)-14.60%
Gross Profit (ttm)N/A
EBITDA -484.31M
Net Income Avi to Common (ttm)-526.24M
Diluted EPS (ttm)-5.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)614.82M
Total Cash Per Share (mrq)5.97
Total Debt (mrq)756.91M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.12
Book Value Per Share (mrq)-3.80

Cash Flow Statement

Operating Cash Flow (ttm)-414.33M
Levered Free Cash Flow (ttm)-261.36M